2007
DOI: 10.1590/s1516-31802007000400012
|View full text |Cite
|
Sign up to set email alerts
|

The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients' quality of life

Abstract: CONTEXT AND OBJECTIVE:Peripheral arterial occlusive disease (PAOD) is a prevalent atherosclerotic disorder characterized by limb pain on exertion, limb loss and a high mortality rate. Because of its chronic nature, it often has a negative impact on patients' quality of life (QOL). This study aimed to assess QOL among patients with PAOD that was treated by endovascular intervention using femoral and popliteal percutaneous transluminal balloon angioplasty (PTBA). DESIGN AND SETTING:This study was local, prospect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
2

Year Published

2010
2010
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 2 publications
(5 reference statements)
0
4
0
2
Order By: Relevance
“…Two of them were large European multi-country studies that involved more than one CEE country [45,46]. Overall 152 reports on country level results were obtained: Austria (n=11) [47][48][49][50][51][52][53][54][55][56][57], Bulgaria (n=6) [45,46,58,59,13], Czech Republic (n=18) [60,61,45,46,[62][63][64][65][66]20,[67][68][69][70][71][72][73][74], Hungary (n=47) [11,75,76,45,[77][78][79][80][81][82][83][84][85][86]…”
Section: Search Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Two of them were large European multi-country studies that involved more than one CEE country [45,46]. Overall 152 reports on country level results were obtained: Austria (n=11) [47][48][49][50][51][52][53][54][55][56][57], Bulgaria (n=6) [45,46,58,59,13], Czech Republic (n=18) [60,61,45,46,[62][63][64][65][66]20,[67][68][69][70][71][72][73][74], Hungary (n=47) [11,75,76,45,[77][78][79][80][81][82][83][84][85][86]…”
Section: Search Resultsmentioning
confidence: 99%
“…Main study characteristics are displayed in Table 2. The first EQ-5D studies in CEE were published from Slovenia (2000) [170], Hungary (2001) [114], Austria and Poland (2003) [51,181], followed by Slovakia (2004) [168], the Czech Republic (2007) [70,71], Romania (2013) [45] and Bulgaria (2014) [13]. In the past 15 years, the number of publications has steadily increased in the region (Figure 2).…”
Section: Characteristics Of the Studiesmentioning
confidence: 99%
“…Overall, 45 reports on country-level EQ-5D scores were obtained. The majority of studies were performed in Poland (n = 24, 53%) , followed by Czech Republic (n = 8) [21,22,[43][44][45][46][47][48], and Slovenia (n = 5) [21,22,[49][50][51]. We also identified two studies from Bulgaria [21,22], Hungary [22,52], and Romania [21,22] and single studies from Austria [53] and Slovakia [54].…”
Section: Representation Of Different Countriesmentioning
confidence: 99%
“…EQ-5D index scores were calculated in 47% (n = 17) of the included studies, and they were based on Polish (n = 6) [19,20,25,26,30,42], English (n = 4) [21,22,26,52], European (n = 4) [43][44][45]48], or Slovenian tariffs (n = 1) [51] ( Supplementary Table 1 -see journal website). Three papers did not report the details of the value sets used for EQ-5D index calculation [37,40,47]. Regarding the two other outcomes, EQ VAS results were reported in 31 (86%) articles and the percentage of responses across the five health-dimensions (health profile) was reported in 19 (53%).…”
Section: Characteristics Of Included Studiesmentioning
confidence: 99%
“…Caracteriza-se por dor, cãibra, sensação de formigamento ou queimação na região da musculatura isquêmica afetada, que surge ao caminhar e cessa com repouso. Varia entre cada indivíduo, pois depende do grau de isquemia muscular e do desenvolvimento da circulação colateral [1][2][3][6][7][8][9][10]. A evolução da doença pode gerar isquemia crítica, gangrena e consequente amputação do membro [1,2].…”
Section: Introductionunclassified